Genomic sequencing has come a long way in a short time, and its potential to drive even faster innovations in precision medicine is enormous. To capitalize on that opportunity, however, health systems ...

Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...

This eBook explores next-generation sequencing (NGS) methods and their applications in neurological and cancer research, with key content from BioTechniques’ digital hub and Taylor & Francis journals, ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before ...

The growing use of precision medicine and genomics drives the sector. The global next-generation sequencing services market is expected to reach $8.77b by 2030 at a compound annual growth rate (CAGR) ...

With the MiSeq™ i100 Series, Illumina continues to set the highest standards. Advancements in system design, sequencing chemistry, and data analysis deliver the simplest, fastest benchtop sequencing ...